approval
saveACTEMRA (TOCILIZUMAB) — FDA approval
community read0 votes
Sponsor: GENENTECH. Form: INJECTABLE. Route: INTRAVENOUS, SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- phase 1 completionChugai Pharmaceutical Co Ltd — tocilizumab (Phase I Trial Completion)Apr 30, 2026 · 160d ago
- approvalACTEMRA (TOCILIZUMAB) — FDA approvalDec 10, 2025 · 301d ago
- approvalACTEMRA (TOCILIZUMAB) — FDA approvalDec 10, 2025 · 301d ago
- approvalACTEMRA (TOCILIZUMAB) — FDA approvalAug 8, 2025 · 425d ago
- approvalACTEMRA (TOCILIZUMAB) — FDA approvalAug 8, 2025 · 425d ago
- approvalACTEMRA (TOCILIZUMAB) — FDA approvalDec 10, 2024 · 666d ago
- approvalACTEMRA (TOCILIZUMAB) — FDA approvalDec 10, 2024 · 666d ago
- approvalACTEMRA (TOCILIZUMAB) — FDA approvalSep 20, 2024 · 747d ago
same company · ±60 days · 6
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalSep 20, 2024
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalSep 19, 2024
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalSep 19, 2024
- approvalEVRYSDI: EVRYSDI (RISDIPLAM) — FDA approvalSep 17, 2024
- approval(atezolizumab + hyaluronidase (human recombinant)): TECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approvalSep 12, 2024
- approvalinavolisib: ITOVEBI (INAVOLISIB) — FDA approvalOct 10, 2024
🐶 often sniffed alongside
top 8- tagApproval264 co-mentions · 72 sources
- drugACTEMRA253 co-mentions · 73 sources
- drugTYENNE16 co-mentions · 8 sources
- companyFresenius Kabi USA LLC8 co-mentions · 8 sources
- drugRNS-608 co-mentions · 8 sources
- drugAVTOZMA8 co-mentions · 4 sources
- companyCelltrion Inc4 co-mentions · 4 sources
- companyChugai Pharmaceutical Co Ltd1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that